Compagnie Lombard Odier SCmA - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 156 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 4.14 and the average weighting 0.2%.

Quarter-by-quarter ownership
Compagnie Lombard Odier SCmA ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$8,728,000
+51241.2%
829,681
+45993.4%
0.19%
Q4 2016$17,000
-5.6%
1,8000.0%0.00%
-100.0%
Q3 2016$18,000
+50.0%
1,8000.0%0.00%
Q2 2016$12,000
-25.0%
1,8000.0%0.00%
Q1 2016$16,000
-33.3%
1,8000.0%0.00%
-100.0%
Q4 2015$24,000
+26.3%
1,8000.0%0.00%0.0%
Q3 2015$19,000
-61.2%
1,8000.0%0.00%
-50.0%
Q2 2015$49,000
-10.9%
1,8000.0%0.00%0.0%
Q1 2015$55,0001,8000.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,180,700$137,941,00010.27%
Palo Alto Investors LP 4,299,901$82,601,0006.92%
Fairmount Funds Management LLC 562,351$10,803,0006.55%
Avoro Capital Advisors LLC 7,000,000$134,470,0004.54%
Pinz Capital Management, LP 8,820$1,694,0004.44%
Birchview Capital, LP 148,000$2,843,0002.52%
Elk Creek Partners, LLC 699,951$13,446,0002.31%
Parkman Healthcare Partners LLC 215,802$4,146,0001.92%
EAM Global Investors LLC 136,402$2,620,0001.53%
SPHERA FUNDS MANAGEMENT LTD. 550,000$10,566,0001.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders